2020 annual financial data
NeuroSense Therapeutics 2020 Operating margin
NeuroSense Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -2,888,000 USD and net income was -2,828,000 USD.
Operating cash flow was -695,000 USD.
Get free NeuroSense Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -2,888,000 USD
- Net income
- -2,828,000 USD
- Operating cash flow
- -695,000 USD